Close
Solutions
Online Inquiry
Global Services

KIR Typing Service

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Equipped with state-of-the-art facilities and experienced immunology experts, Creative Biolabs is dedicated to genotyping services for our global clients. With advanced technology platforms and extensive expertise, we are ready to provide you with high-quality KIR typing services.

Background

As an important lymphocyte population in the innate immune system, natural killer (NK) cells are critical in lysing the infected cells or cancer cells without adaptive immune response mediated by antigen stimulation. Killer-cell immunoglobulin-like receptors (KIRs) are type I transmembrane glycoproteins expressed on NK cells, and they can interact with major histocompatibility (MHC) class I molecules to mediate the inhibitory or activated NK cell activities. For normal healthy tissues, negative regulation of NK cell happens via the recognition of MHC molecules with inhibitory KIRs. For infected cells or transformed cells, NK cells can lyse the target cells through activated KIRs. KIR molecules are highly polymorphic, and the sequences are different between individuals. KIR family consists of 15 gene loci, including KIR2DL1, KIR2DL2/L3, KIR2DL4, KIR2DL5A, KIR2DL5B, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DL1/S1, KIR3DL2, KIR3DL3, and two pseudogenes, KIR2DP1 and KIR3DP1 (see Fig.1).

KIR proteins. Fig.1 KIR proteins. (Source from IPD-KIR)

KIR Typing Service

To investigate the polymorphism of KIRs, Creative Biolabs offers a series of KIR typing services to our clients, including KIR typing at the DNA and mRNA level, as well as KIR phenotyping by FACS.

  • Our KIR typing service allows the detection of all human KIR genes and alleles at the genomic DNA and transcriptomic mRNA level. Sequence-specific primers are designed to analyze the KIR genes. With several years of efforts, our scientists are able to detect all 15 human KIRs and their alleles.
  • We also developed an advanced High-Throughput Sequencing (HTS) platform to analyze the KIR genes at the highest resolution. With this approach, we can determine copy number by reading depth, and also high-resolution genotypes of all KIR genes. This HTS platform also is applicable to other highly polymorphic genes, such as HLA genes.

Pipeline for analyzing sequence data from highly polymorphic KIRs. Fig.2 Pipeline for analyzing sequence data from highly polymorphic KIRs. (Norman, 2016)

Highlight Features

  • 100% capacity to investigate all KIR genes
  • 100% accuracy for the delivered results
  • 100% dedication to all the details of every program

With novel technology platform and professional senior scientists, Creative Biolabs provides a full spectrum of KIR typing services covering all KIR genes and alleles. We are committed to offering customized solutions to fit our clients' specific requirements. Please feel free to contact us for more details.

Reference

  1. Norman, Paul J., et al. "Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing." The American Journal of Human Genetics 99.2 (2016): 375-391.
Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.